Stock Buybacks (Quarterly) Chart

Historical Stock Buybacks (Quarterly) Data

View and export this data back to 2018. Start Trial.
Date Value
June 30, 2026 -78.38M
March 31, 2026 -162.52M
December 31, 2025 -1.041M
September 30, 2025 -0.101M
June 30, 2025 -2.406M
March 31, 2025 -0.598M
December 31, 2024 -1.25M
September 30, 2024 -0.071M
June 30, 2024 -3.011M
March 31, 2024 -0.221M
December 31, 2023 -1.767M
September 30, 2023 -0.343M
June 30, 2023 -3.347M
March 31, 2023 -2.31M
December 31, 2022 -2.088M
September 30, 2022 -2.044M
Date Value
June 30, 2022 -3.14M
March 31, 2022 -28.95M
December 31, 2021 -5.742M
September 30, 2021 -88.90M
June 30, 2021 -3.593M
March 31, 2021 -2.352M
December 31, 2020 -0.519M
September 30, 2020 -324.37M
June 30, 2020 -208.94M
March 31, 2020 -0.143M
December 31, 2019 -130.16M
September 30, 2019 0.00
June 30, 2019 0.00
March 31, 2019 0.00
December 31, 2018 -10.44M
September 30, 2018 0.00

Stock Buyback Definition

Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.

Read full definition.

Stock Buybacks (Quarterly) Range, Past 5 Years

View Stock Buybacks (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Stock Buybacks (Quarterly) Benchmarks

View Stock Buybacks (Quarterly) Benchmarks
Start Trial
Moderna, Inc. -23.00M
Vaxcyte, Inc. -7.761M
Caribou Biosciences, Inc. -17.94M
Arrowhead Pharmaceuticals, Inc. -29.86M
Oncolytics Biotech, Inc. -6.704M